BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436


SEARCH JOBS




Industry
Pharmaceutical






 Company News
IntelGenx Corp. Grants Stock Options 12/9/2014 11:04:15 AM
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014 10:40:15 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Announce Acceptance For Review Of European Marketing Application For RIZAPORT For Migraines 12/1/2014 10:30:25 AM
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014 9:16:05 AM
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014 10:17:30 AM
IntelGenx Corp. To Present At Singular Research's Best Of The Uncovered 2014 NYC Fall Conference 11/20/2014 2:01:19 PM
IntelGenx Corp. Announces Successful Clinical Study For Schizophrenia 11/3/2014 8:46:42 AM
IntelGenx Corp. Founder Returns As President And CEO 10/2/2014 6:40:58 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103) 10/1/2014 9:12:10 AM
IntelGenx Corp. To Present At Singular Research 9th Annual Best Of The Uncovereds Conference 9/17/2014 10:09:41 AM
12345678910...